Hiding in Plain Sight: an Approach to Treating Patients with Severe COVID-19 Infection.
mBio
; 11(2)2020 03 20.
Article
em En
| MEDLINE
| ID: mdl-32198163
Patients with COVID-19 infection are at risk of acute respiratory disease syndrome (ARDS) and death. The tissue receptor for COVID-19 is ACE2, and higher levels of ACE2 can protect against ARDS. Angiotensin receptor blockers and statins upregulate ACE2. Clinical trials are needed to determine whether this drug combination might be used to treat patients with severe COVID-19 infection.
Palavras-chave
Texto completo:
1
Bases de dados:
MEDLINE
Assunto principal:
Pneumonia Viral
/
Receptores Virais
/
Infecções por Coronavirus
/
Receptor Tipo 2 de Angiotensina
/
Betacoronavirus
Limite:
Humans
Idioma:
En
Revista:
MBio
Ano de publicação:
2020
Tipo de documento:
Article
País de afiliação:
França